Maria Lizarazo Jimenez
1
* , MD ;
Ana Gabriela Claros
1
* , MD ;
Kieran Green
1
, PhD ;
David Toro-Tobon
1, 2
, MD ;
Felipe Larios
1
, MD ;
Sheena Asthana
3
, PhD ;
Camila Wenczenovicz
1
, MD ;
Kerly Guevara Maldonado
1
, MD ;
Luis Vilatuna-Andrango
1
, MD ;
Ana Cristina Proano
1
, MD ;
Satya Sai Sri Bandi
1
, MBBS ;
Shubhangi Bagewadi
1
, MBBS ;
Megan E Branda
1, 4
, MS ;
Misk Al Zahidy
1
, MS ;
Saturnino Luz
5
, PhD ;
Mirella Lapata
5
, PhD ;
Juan P Brito
1, 2
, MD ;
Oscar J Ponce-Ponte
1, 6
, MD
1
Department of Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Knowledge and Evaluation Research Unit, Care and AI Laboratory, Mayo Clinic, Rochester, MN, United States
2
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, United States
3
Centre for Health Technology, University of Plymouth, Plymouth, United Kingdom
4
Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States
5
Usher Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom
6
Derriford Hospital, University Hospitals Plymouth NHS Trust, Plymouth, England, United Kingdom
*these authors contributed equally
Corresponding Author:
-
Oscar J Ponce-Ponte, MD
-
Department of Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Knowledge and Evaluation Research Unit, Care and AI Laboratory
-
Mayo Clinic
-
100 2nd St SW
-
Rochester, MN 55905
-
United States
-
Phone:
1 (507) 284-2511
-
Email: ponceoscarj@gmail.com